Biobanking for Cancer

(PMT Trial)

This trial helps cancer patients by collecting extra tumor samples left over from their regular diagnostic tests. Researchers use these samples to gain insights into cancer behavior. Participants also provide access to their medical records and agree to future contact for research projects. This trial suits adults with cancer who are willing to share their medical data and samples to support research. Known as the Personalize My Treatment (PMT) Registry, it aims to improve cancer treatment by understanding each person's unique cancer journey.

As an unphased trial, it offers patients the chance to contribute to groundbreaking research that could lead to more personalized cancer treatments.

Research has shown that patient registries, such as the Personalize My Treatment (PMT) Registry, are generally safe. These registries collect real-world information about patient outcomes and safety without introducing new drugs or treatments, eliminating direct safety concerns from trying new medications. Instead, registries gather data from patients' existing medical records and samples. Well-designed registries offer a real-world view of medical practice and can uncover unique safety information. However, they do not involve the risks typically associated with new drug trials. Participants primarily share their data and samples, a process generally well-tolerated.¹²³⁴⁵

The Personalize My Treatment (PMT) Registry is exciting to researchers because it aims to tailor treatments specifically to individual patient needs, rather than using a one-size-fits-all approach. Unlike standard treatments that may not account for individual differences, this registry focuses on personalizing care, potentially leading to more effective and targeted outcomes. Researchers hope to learn which treatment strategies work best for specific patient profiles, ultimately enhancing the effectiveness and efficiency of healthcare by minimizing trial and error in treatment plans.

Research has shown that patient registries, such as the Personalize My Treatment (PMT) Registry, provide a real-world perspective on treatment effectiveness. Well-designed registries enable doctors to observe patient responses and assess treatment efficacy over time. By collecting data from numerous patients, registries contribute to the development of improved and personalized treatment plans. Studies from cancer registries have demonstrated that their findings often align with those from controlled trials, indicating that registries can reliably reflect treatment outcomes outside strict clinical settings.¹²³⁶⁷